ScottA.WaldmanMD

Physician

Dr. Waldman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
132 S 10th St
# 1170
Philadelphia, PA 19107
Phone+1 215-955-6086

Fax+1 215-955-5681

Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1987 - 1990
Stanford University School of MedicineClass of 1987

Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer Start of enrollment: 2013 Oct 01
Completed
Phase 1
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer Start of enrollment: 2019 Oct 30
Active, not recruiting
Phase 2
GCC Agonist Signal in the Small Intestine Start of enrollment: 2022 Nov 30
Recruiting
Phase 1
Roles: Contact, Principal Investigator

PubMed

2 citations
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults.
Lara Cheslow, Matthew Byrne, Jessica S Kopenhaver, Lorraine Iacovitti, Richard J Smeyne
NPJ Parkinson's Disease. 2024-04-13
6 citations
Intestinal neuropod cell GUCY2C regulates visceral pain.
Joshua R Barton, Annie K Londregan, Tyler D Alexander, Ariana A Entezari, Shely Bar-Ad
The Journal of Clinical Investigation. 2023-02-15
Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients.
Madison M Crutcher, Adam E Snook, Scott A Waldman
Expert Review of Clinical Pharmacology. 2022-11-01

FDA Panel Says Poziotinib’s Benefits Don’t Outweigh Risks in NSCLC With HER2 Exon 20 MutationsSeptember 22nd, 2022
Climate Science Deniers Turn to Attacking Coronavirus ModelsApril 15th, 2020
Positive Phase I Results for Colorectal Cancer VaccineMay 3rd, 2019
Join now to see all

Gastro Intestinal CancerNational Cancer Institute2010–2011
Clinical Pharmacology Training ProgramNational Institute Of General Medical Sciences1997–2011
Occult Lymph Node Metastases And Racial Disparities In Colon Cancer OutcomesNational Cancer Institute2009–2010
Training Program In Human InvestigationNational Center For Research Resources2005–2009
Guanylyl Cyclase C In Blood And Colorectal CancerNational Cancer Institute2003–2008
Short-Term Training Program In Translational Cancer ReseNational Cancer Institute2003–2007
Guanylyl Cyclase C As A Bi0marker For Colorectal CancerNational Cancer Institute2002–2006
Training Program In Human InvestigationNational Heart, Lung, And Blood Institute2000–2004
Core--Developmental TherapeuticsNational Cancer Institute2001–2002
Short Term Training Program--Translational Cancer ResearNational Cancer Institute1997–2001
Guanylyl Cyclase C In Blood And Colorectal CancerNational Cancer Institute1999–2000
Allosteric Inhibition Of Guanylyl Cyclase By NucleotidesNational Heart, Lung, And Blood Institute1998–2000
Vitamin D3 25-Hydroxylase Characterization &RegulationNational Institute Of General Medical Sciences1999
Guanylyl Cyclase C As A Biomarker For Colorectal CancerNational Cancer Institute1998–1999
Molecular Characterization Of E Coli Toxin ReceptorsNational Institute Of Diabetes And Digestive And Kidney Diseases1992